VanEck Pharmaceutical ETF
PPH
PPH
53 hedge funds and large institutions have $48.9M invested in VanEck Pharmaceutical ETF in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
16
Reduced
13
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$4.69M |
2 |
HighTower Advisors
Chicago,
Illinois
|
+$2.09M |
3 |
B
Baird
Milwaukee,
Wisconsin
|
+$1.35M |
4 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$618K |
5 |
U
UBS
Zurich,
Switzerland
|
+$592K |
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$5.68M |
2 |
Goldman Sachs
New York
|
-$678K |
3 |
MIM
Macroview Investment Management
Bethesda,
Maryland
|
-$401K |
4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$207K |
5 |
CCT
Country Club Trust
Kansas City,
Missouri
|
-$201K |